01095nas a2200181   4500000000100000008004100001260001200042653001300054100001300067700002300080700001400103700001400117700002000131245008300151856005800234520060700292022001400899       2020                            d  c08/202010aCovid-191 aSantos V1 aQuintans-Júnior L1 aBarboza W1 aAraújo A1 aMartins-Filho P00aClinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy.  uhttps://onlinelibrary.wiley.com/doi/10.1111/jdv.168993 a<p>The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a highly infectious virus that causes coronavirus disease 2019 (COVID-19), has raised important questions about the target groups at risk of illness and/or death. COVID-19 mortality has been higher in men, older people, unassisted by health systems and those having non-communicable disease. However, information is still lacking on how COVID-19 can affect people with infectious disease. Herein, we described the clinical features and outcomes in patients with COVID-19 and leprosy in an endemic area in Brazil.</p>  a1468-3083